Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorÖzalp, G. R.
dc.contributor.authorGül, Z.
dc.contributor.authorSeyidoğlu, Nilay
dc.contributor.authorBüyüküysal, L.
dc.date.accessioned2023-04-20T08:02:30Z
dc.date.available2023-04-20T08:02:30Z
dc.date.issued2022
dc.identifier.issn1792-2720
dc.identifier.urihttps://doi.org/10.12681/jhvms.26307
dc.identifier.urihttps://hdl.handle.net/20.500.11776/10965
dc.description.abstractThe present study aimed to evaluate the GSH and MDA levels in dog???s serum and vital organs of aborted fetuses, after application of two abortifacient. Animals of group I (n = 6) were treated twice with subcutaneous injection of 10 mg/kg aglepristone and group II (n = 3) received prostaglandin F2?? at a dose of 125 ??g/kg every 12 hours until abortion process completed. Hematologic examinations and sedimentation rates were performed of bitches. The duration between the first occurrence of vaginal discharge to first expulsion of fetuses ranged between 14-29 hours (mean: 22.6??5.5 h) and 24-33 hours in group I and II, respectively. Both treatments significantly increased the serum MDA levels (P<0.01); however aglepristone increased the MDA levels throughout the study, prostaglandin enhanced plasma MDA levels only on day 1. GSH levels were significantly lower in aglepristone-treated bitches than prostaglan-din-treated animals (P 0.05). The treatments resulted in similar MDA levels in liver and heart tissues (P 0.05). GSH levels in kidney, muscle and heart tissues did not differ between groups (P>0.05), aglepristone resulted reduced GSH levels in liver tissue (P<0.05). High MDA levels could be evaluated as a useful marker for fetal suffering in pregnancy controls. The MDA and GSH levels, measured in vital organs of fetuses, could suggest possible toxic effects of aborti-facients in newborns, as both medical agents are being used in parturition induction.en_US
dc.description.sponsorshipDepartment of Psychiatry Yale Tobacco Center of Regulatory Scienceen_US
dc.description.sponsorshipWe gratefully acknowledge Dr. Deniz Bagdas, from Department of Psychiatry Yale Tobacco Center of Regulatory Science, Yale University, USA for technical support with measurements and statistical evaluationen_US
dc.language.isoengen_US
dc.publisherHellenic Veterinary Medical Socen_US
dc.identifier.doi10.12681/jhvms.26307
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPregnancy Terminationen_US
dc.subjectMalondialdehydeen_US
dc.subjectReduced Glutathioneen_US
dc.subjectProstaglandinen_US
dc.subjectAglepristoneen_US
dc.subjectDogen_US
dc.subjectProgesterone Antagonist Aglepristoneen_US
dc.subjectPregnancy Terminationen_US
dc.subjectUnwanted Pregnancyen_US
dc.subjectMidterm Pregnancyen_US
dc.subjectDopamine Agonisten_US
dc.subjectVitamin-Aen_US
dc.subjectInductionen_US
dc.subjectCombinationen_US
dc.subjectBitchesen_US
dc.subjectCloprostenolen_US
dc.titleOxidative stress in dogs during mid-gestation abortion: Fetal and maternal antioxidant alterations with clinical and hematological featuresen_US
dc.typearticleen_US
dc.relation.ispartofJournal of the Hellenic Veterinary Medical Societyen_US
dc.departmentFakülteler, Veteriner Fakültesi, Temel Bilimler Bölümü, Fizyoloji Ana Bilim Dalıen_US
dc.identifier.volume73en_US
dc.identifier.issue2en_US
dc.identifier.startpage4041en_US
dc.identifier.endpage4048en_US
dc.institutionauthorSeyidoğlu, Nilay
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid23985710500
dc.authorscopusid56086542900
dc.authorscopusid55921065100
dc.authorscopusid6507171811
dc.identifier.wosWOS:000825157800017en_US
dc.identifier.scopus2-s2.0-85134398486en_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster